Evolent Health (EVH) Gross Profit (2015 - 2026)

Evolent Health's Gross Profit history runs 12 years deep, the most recent figure standing at $83.8 million for Q1 2026.

• On a quarterly basis, Gross Profit fell 18.25% year-over-year to $83.8 million in Q1 2026; TTM through Mar 2026 was $381.2 million, a 4.23% increase from a year earlier, with the FY2025 full-year figure at $399.9 million, up 8.86% from the prior year.
• Gross Profit declined to $83.8 million in Q1 2026 per EVH's latest filing, from $97.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $124.4 million in Q3 2023 and bottomed at $70.2 million in Q2 2022.
• The 5-year median for Gross Profit is $99.8 million (2025), against an average of $95.8 million.
• Across the five-year window, Gross Profit surged 66.87% in 2023 and tumbled 35.15% in 2024, its largest moves.
• Year by year, Gross Profit stood at $83.1 million in 2022, then gained by 22.35% to $101.6 million in 2023, then retreated by 25.5% to $75.7 million in 2024, then rose by 28.45% to $97.3 million in 2025, then decreased by 13.86% to $83.8 million in 2026.
• Per Business Quant, the three latest EVH Gross Profit figures stand at $83.8 million (Q1 2026), $97.3 million (Q4 2025), and $99.8 million (Q3 2025).